Summary
Boston Scientific Corporation (BSX) has filed a Form 8-K report dated October 21, 2025, to announce its financial results for the third quarter ended September 30, 2025. The report primarily directs investors to a press release, furnished as Exhibit 99.1, which contains the detailed financial outcomes and operational performance for the quarter. Investors should refer to this press release for comprehensive information regarding revenue, profitability, segment performance, and any forward-looking guidance provided by the company. This filing serves as a notification mechanism for the release of the company's quarterly financial performance. It is important to note that the information within this Item 2.02 and its accompanying exhibit is furnished and not deemed 'filed' for the purposes of Section 18 of the Exchange Act. Therefore, while the information is publicly available, it does not carry the same legal implications as information that is formally filed. Investors should consult the press release for substantive details on BSX's Q3 2025 results.
Key Highlights
- 1Boston Scientific Corporation (BSX) filed an 8-K on October 21, 2025.
- 2The filing announces financial results for the third quarter ended September 30, 2025.
- 3Detailed financial information is provided in a press release furnished as Exhibit 99.1.
- 4Investors are directed to the press release for Q3 2025 earnings and financial condition updates.
- 5The press release contains information previously announced by the company on October 22, 2025.
- 6Information in Item 2.02 and Exhibit 99.1 is furnished, not filed, under Section 18 of the Exchange Act.
- 7Exhibit 104 provides the Cover Page Interactive Data File in XBRL format.